Elevated PGRN levels are tightly relevant to multiple inflammatory diseases, such as arthritis (Fu et al., 2017), type two diabetes (Xu, Zhou, et al., 2015), osteonecrosis (Han et al., 2017), in which PGRN inhibits inflammation and is associated with poor prognosis. This evidence concerns the gene GRN and osteonecrosis.